Skip to main content

Advertisement

SpringerLink
Log in

Clinical Effects from Ingestion of Lappaconitine, an Aconitum Alkaloid with Sodium Channel Blocking Effects

  • Case Report
  • Published:
Journal of Medical Toxicology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Doering NA, et al. A copper-mediated conjugate addition approach to analogues of aconitine-type diterpenoid alkaloids. J Org Chem. 2018;83(20):12911–20.

    Article  CAS  Google Scholar 

  2. Wright SN. Irreversible block of human heart (hH1) sodium channels by the plant alkaloid lappaconitine. Mol Pharmacol. 2001;59(2):183–92.

    Article  CAS  Google Scholar 

  3. Valeev AE, Verkhratskiĭ AN, Dzhakhangirov FN. The effect of allapinine on the sodium currents of isolated trigeminal ganglion neurons and cardiomyocytes of rats. Neirofiziologiia. 1990;22(2):201–6.

    CAS  PubMed  Google Scholar 

  4. Heubach JF, Schüle A. Cardiac effects of lappaconitine and N-deacetyllappaconitine, two diterpenoid alkaloids from plants of the Aconitum and Delphinium species. Planta Med. 1998;64(1):22–6.

    Article  CAS  Google Scholar 

  5. Wang SY, Wang GK. Voltage-gated sodium channels as primary targets of diverse lipid-soluble neurotoxins. Cell Signal. 2003;15(2):151–9.

    Article  CAS  Google Scholar 

  6. Lin TJ, et al. Common toxidromes of plant poisonings in Taiwan. Clin Toxicol (Phila). 2009;47(2):161–8.

    Article  Google Scholar 

  7. Baselt RC. Disposition of toxic drugs and chemicals in man. 12th ed. Seal Beach, CA: Biomedical Publications; 2020. pp 32–33.

  8. Nelson LS, Goldrank LR. Plants. In: Nelson LS, Howland MA, Lewin NA, Smith SW, Goldfrank LR, Hoffman RS (eds). Goldfrank’s toxicologic emergencies. 11th ed. New York, NY: McGraw-Hill; 2019. pp. 1597–1616.

  9. Nelson LS, Balick MJ (eds). Handbook of poisonous and injurious plants. 3rd ed. New York, NY: Springer US; 2020. pp 60–62.

  10. Frohne D, Pfander HJ. Poisonous plants. A handbook for doctors, pharmacists, toxicologists, biologists and veterinarians. 2nd ed. London, UK: Manson Publishing; 2005. pp. 318–322.

  11. Rätsch C. The encyclopedia of psychoactive plants: Ethnopharmacology and its applications. Rochester, VT: Park Street Press; 2005. pp. 31–38.

  12. Tan JJ, et al. Two new 18-carbon norditerpenoid alkaloids from Aconitum sinomontanum. J Asian Nat Prod Res. 2006;8(6):535–9.

    Article  CAS  Google Scholar 

  13. Wang FP, et al. Five new norditerpenoid alkaloids from Aconitum sinomontanum. J Asian Nat Prod Res. 2001;3(1):15–22.

    Article  CAS  Google Scholar 

  14. Luo YR, Goodnough R, Yun C, Wu AHB, Lynch KL. Establishment of a high-resolution liquid chromatography-mass spectrometry spectral library for screening toxic natural products. J Anal Toxicol. 2022;46(3):303–21.

    Article  Google Scholar 

  15. Fuchs J, et al. Acute plant poisoning: analysis of clinical features and circumstances of exposure. Clin Toxicol (Phila). 2011;49(7):671–80.

    Article  Google Scholar 

  16. Smith SW, et al. Bidirectional ventricular tachycardia resulting from herbal aconite poisoning. Ann Emerg Med. 2005;45(1):100–1.

    Article  Google Scholar 

  17. Coulson JM, Caparrotta TM, Thompson JP. The management of ventricular dysrhythmia in aconite poisoning. Clin Toxicol (Phila). 2017;55(5):313–21.

    Article  CAS  Google Scholar 

  18. POWO. Plants of the World Online. Facilitated by the Royal Botanic Gardens, Kew. 2022. http://www.plantsoftheworldonline.org/. Accessed 10 Mar 2022.

  19. Bryzgalov AO, et al. Lappaconitine: influence of halogen substituent on the antiarrhythmic activity. Cardiovasc Hematol Agents Med Chem. 2013;11(3):211–7.

    Article  CAS  Google Scholar 

  20. Erlikh AD. The study of evidence base for the use of lappaconitine hydrobromide in patients with atrial fibrillation. Kardiologiia. 2016;56(3):48–53.

    Article  CAS  Google Scholar 

  21. Pang L, et al. Synthesis, in vitro and in vivo biological evaluation of novel lappaconitine derivatives as potential anti-inflammatory agents. Acta Pharm Sin B. 2020;10(4):628–45.

    Article  CAS  Google Scholar 

  22. Li YF, et al. Inhibitory effects of lappaconitine on the neuronal isoforms of voltage-gated sodium channels. Acta Pharmacol Sin. 2019;40(4):451–9.

    Article  CAS  Google Scholar 

  23. Wang JL, et al. Structure-analgesic activity relationship studies on the C(18)- and C(19)-diterpenoid alkaloids. Chem Pharm Bull (Tokyo). 2009;57(8):801–7.

    Article  CAS  Google Scholar 

  24. Ono M, Satoh T. Pharmacological studies of lappaconitine. Occurrence of analgesic effect without opioid receptor. Res Commun Chem Pathol Pharmacol. 1989;63(1):13–25.

    CAS  PubMed  Google Scholar 

  25. Guo T, et al. Nanostructured lipid carriers for percutaneous administration of alkaloids isolated from Aconitum sinomontanum. J Nanobiotechnol. 2015;13:47.

    Article  Google Scholar 

  26. Rakhmanova MM, Sokolov SF. Efficacy and safety of allapinine and quinidine bisulphate in the treatment of patients with persistent atrial fibrillation after cardioversion. Kardiologiia. 2014;54(9):33–8.

    Article  CAS  Google Scholar 

  27. VakhitovaIu V, et al. To the mechanisms of antiarrhythmic action of Allapinine. Bioorg Khim. 2013;39(1):105–16.

    CAS  Google Scholar 

  28. Chan TY. Aconite poisoning. Clin Toxicol (Phila). 2009;47(4):279–85.

    Article  CAS  Google Scholar 

  29. Chan TY. Hidden aconite roots in herbal medicines. Clin Toxicol (Phila). 2010;48(1):92.

    Article  Google Scholar 

  30. Xie FM, et al. Studies on the metabolism of lappaconitine in human. Identification of the metabolites of lappaconitine in human urine by high performance liquid chromatography. Biomed Chromatogr. 1990;4(1):43–6.

    Article  CAS  Google Scholar 

  31. Eastlack SC, Cornett EM, Kaye AD. Kratom-pharmacology, clinical implications, and outlook: a comprehensive review. Pain Ther. 2020;9(1):55–69.

    Article  Google Scholar 

  32. Eggleston W, et al. Kratom use and toxicities in the United States. Pharmacotherapy. 2019;39(7):775–7.

    Article  Google Scholar 

  33. Schmitt J, Bingham K, Knight LD. Kratom-associated fatalities in Northern Nevada-what mitragynine level is fatal? Am J Forensic Med Pathol. 2021;42(4):341–9.

    Article  Google Scholar 

  34. National Center for Biotechnology Information. PubChem Compound Summary for CID 5570, Trigonelline. 2022. https://pubchem.ncbi.nlm.nih.gov/compound/Trigonelline. Accessed 10 Mar 2022.

  35. Gilroy CM, et al. Echinacea and truth in labeling. Arch Intern Med. 2003;163(6):699–704.

    Article  Google Scholar 

  36. Liberti LE, Der Marderosian A. Evaluation of commercial ginseng products. J Pharm Sci. 1978;67(10):1487–9.

    Article  CAS  Google Scholar 

  37. Yoshida N, et al. Study on health hazards through medicines purchased on the Internet: a cross-sectional investigation of the quality of anti-obesity medicines containing crude drugs as active ingredients. BMC Complement Altern Med. 2015;15(1):430.

    Article  Google Scholar 

Download references

Acknowledgements

We would like to thank our colleagues at University of California San Francisco in Dr. Kara Lynch’s lab who performed the specimen analysis by utilizing their previously described methods.

Funding

Financial support for laboratory testing was provided by a seed grant from the University of Iowa Department of Emergency Medicine.

Author information

Authors and Affiliations

  1. Division of Medical Toxicology, Department of Emergency Medicine, University of Iowa, Iowa City, IA, USA

    Daniel J. McCabe

  2. Iowa Poison Control Center, Sioux City, IA, USA

    Daniel J. McCabe

  3. Department of Emergency Medicine, University of Iowa Hospitals and Clinics, 200 Hawkins Drive, Iowa City, IA, 52242, USA

    Daniel J. McCabe

Authors
  1. Daniel J. McCabe
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Dr. McCabe coordinated and supervised the collection of clinical data, performed clinical interpretation, reviewed and conceptualized the analysis results, reviewed and revised the manuscript, and approved the final manuscript as submitted and agree to be accountable for all aspects of the work.

Corresponding author

Correspondence to Daniel J. McCabe.

Ethics declarations

Consent of Patient

Consent for publication of this case was obtained and provided to the journal in accordance with JMT policy.

Conflicts of Interest

None.

Additional information

Supervising Editor: Andis Graudins, MB BS, Ph D

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Previous Presentation

Data in this manuscript were previously presented at ACMT’s Annual Scientific Meeting (Virtual), 2022.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

McCabe, D.J. Clinical Effects from Ingestion of Lappaconitine, an Aconitum Alkaloid with Sodium Channel Blocking Effects. J. Med. Toxicol. 18, 243–247 (2022). https://doi.org/10.1007/s13181-022-00896-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13181-022-00896-1

Keywords

Search

Navigation